<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04656197</url>
  </required_header>
  <id_info>
    <org_study_id>BASEC 2019-01670</org_study_id>
    <nct_id>NCT04656197</nct_id>
  </id_info>
  <brief_title>The Ocular Microbiome in Patients With Dry Eye Disease</brief_title>
  <official_title>Identification of the Ocular Microbiome and Its Role on Dry Eye Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Inselspital, Berne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Inselspital, Berne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is the characterization of the ocular microbiome in a&#xD;
      healthy cohort and in patients with dry eye disease using whole-metagenome shotgun&#xD;
      sequencing. Secondary objectives are the identification of differences between the ocular&#xD;
      microbiome of healthy controls and patients with dry eye disease as well as between the&#xD;
      ocular and the gut microbiome.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Dry eye disease is considered to be the most common ocular surface disease worldwide. Recent&#xD;
      studies revealed that the ocular microbiome plays an important role in maintaining ocular&#xD;
      surface homeostasis and health. Commensals colonizing the ocular surface seem to support the&#xD;
      local innate immune system. As the ocular microbiome coordinates several functions together&#xD;
      with ocular mucosal and immune epithelial cells, alteration of the microbiome can lead to&#xD;
      changes in the integrity of the ocular surface. This can lead to the development of ocular&#xD;
      surface related diseases such as dry eye. Inflammation seems to be a key component of dry eye&#xD;
      disease in terms of being a propagator as well as a consequence. In contrast to earlier&#xD;
      approaches of identifying the microbiome by cultivating with only limited results, it is now&#xD;
      possible to provide more details regarding all microbiota residing on the ocular surface due&#xD;
      to modern sequencing techniques. Thus, the overall aim of this study is the identification of&#xD;
      the role of the ocular microbiome in dry eye disease.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 30, 2019</start_date>
  <completion_date type="Actual">March 4, 2020</completion_date>
  <primary_completion_date type="Actual">March 4, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Characterization of the ocular microbiome</measure>
    <time_frame>at baseline</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Identification of differences of the ocular microbiome between patients and controls</measure>
    <time_frame>at baseline</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">80</enrollment>
  <condition>Dry Eye Disease</condition>
  <arm_group>
    <arm_group_label>Patients with dry eye disease</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy controls</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Ocular microbiome</intervention_name>
    <description>Taxonomical and functional characterization of the ocular microbiome</description>
    <arm_group_label>Healthy controls</arm_group_label>
    <arm_group_label>Patients with dry eye disease</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      DNA isolated from eye swabs&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Consecutive ongoing recruitment of subjects attending routine follow-ups through the&#xD;
        involved investigators in daily clinical practice at Department of Ophthalmology,&#xD;
        Inselspital, Bern&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients willing to sign informed consent&#xD;
&#xD;
          -  Patients 60 years of age or older&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients not willing or able to sign informed consent&#xD;
&#xD;
          -  Patients younger than 60 years&#xD;
&#xD;
          -  Smoking&#xD;
&#xD;
          -  Wearing contact lenses&#xD;
&#xD;
          -  Recent (3 month) history of use of systemic and/or topical antibiotics&#xD;
&#xD;
          -  Usage of medical eye drops (Lacrycon and other moisturizing eye drops are allowed)&#xD;
&#xD;
          -  Recent (3 month) history of ocular surgery&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martin Zinkernagel, Prof. Dr. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Ophthalmology, Inselspital, Bern</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Ophthalmology, Inselspital</name>
      <address>
        <city>Bern</city>
        <zip>3010</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>November 30, 2020</study_first_submitted>
  <study_first_submitted_qc>November 30, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 7, 2020</study_first_posted>
  <last_update_submitted>November 30, 2020</last_update_submitted>
  <last_update_submitted_qc>November 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Ocular metagenome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dry Eye Syndromes</mesh_term>
    <mesh_term>Keratoconjunctivitis Sicca</mesh_term>
    <mesh_term>Eye Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

